Department
Surgery Sector
Orthopedics, Plastic, Cardiothoracic, Vascular
HBOT Applications
Refractory Osteomyelitis
Standard-of-care adjunctive treatment for chronic osteomyelitis unresponsive to conventional therapy. HBOT enhances leukocyte killing in avascular bone and promotes neovascularization.
Protocol
Pressure
2.0 – 2.4 ATA
Duration
90 min
Sessions
30 – 60
Frequency
Once daily, 5×/week
Evidence basis: UHMS / FDA-Approved
Crush Injuries & Compartment Syndrome
Approved for acute traumatic ischemias. Reduces post-ischemic edema and preserves threatened tissue in severe crush injuries.
Protocol
Pressure
2.0 – 2.4 ATA
Duration
90 min
Sessions
10 – 20
Frequency
Once daily, 5×/week
Evidence basis: UHMS / FDA-Approved
Compromised Skin Grafts & Flaps
Salvage therapy for ischemic reconstructive flaps and skin grafts. Reduces hypoxic necrosis through enhanced tissue oxygenation and angiogenesis.
Protocol
Pressure
2.0 – 2.4 ATA
Duration
90 min
Sessions
20 – 30
Frequency
Once daily, 5×/week
Evidence basis: UHMS / FDA-Approved
Postoperative Recovery (TKA)
Emerging evidence shows HBOT accelerates recovery and reduces muscle damage following total knee arthroplasty and major orthopedic procedures.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
10 – 20
Frequency
Once daily, 5×/week
Evidence basis: Clinical Research
Thermal Burns
Adjunctive treatment for acute thermal burns. Reduces edema, promotes epithelialization, and decreases infection risk.
Protocol
Pressure
2.0 – 2.4 ATA
Duration
90 min
Sessions
20 – 30
Frequency
Once or twice daily
Evidence basis: UHMS / FDA-Approved
Therapeutic Angiogenesis (Cardiac)
Investigational use for chronic stable ischemic heart disease and post-MI left ventricular function improvement through VEGF-mediated angiogenesis.
Protocol
Pressure
2.0 – 2.4 ATA
Duration
90 min
Sessions
30 – 40
Frequency
Once daily, 5×/week
Evidence basis: Investigational